Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that ...

Cal Poly Pomona, through its Singelyn Graduate School of Business and the College of Pharmacy at Western University of Health Sciences have launched a ...

Artificial intelligence (AI) is revolutionising the field of cardiology, offering new hope for patients with cardiovascular ...

A new review suggests that cranberries may in fact be effective at preventing urinary tract infections.

Late-breaking data showed almost all patients achieved normal blood clotting and vessel repair after bentracimab infusion.

DEA and HHS have delayed implementation of two rules for telehealth prescribing of buprenorphine until the end of the year to ...

The Drug Safety Research Unit has announced Linda Härmark as its new Director. She succeeds Professor Saad Shakir who officially steps down from the position after 26 years. Linda joins the DSRU, ...

When I first spoke to Yap Boum II in January, 2025, he had recently become Deputy Incident Manager for the continental ...

Tribune Therapeutics AB, a biotechnology company dedicated to treating the root causes of fibrotic diseases, today announced it has raised EUR 37 million in seed and Series A funding to advance a ...

Programs address the need for disease-modifying therapies targeting root causes of fibrosis Funding will support advancement of CCN-family inhibitor TRX-44 into clinical trials for treatment ...